Form 4: Director Melenikiotou Acquires 79 Shares of Inspire Medical Systems (INSP) in Lieu of Cash Fees

Sentiment:

SEC Form 4 Filing


Georgia Melenikiotou, a director of Inspire Medical Systems, acquired 79 shares of common stock on October 14, 2024, in lieu of cash fees, according to a Form 4 filing with the SEC.

Summary

  • On October 14, 2024, Georgia Melenikiotou, a director of Inspire Medical Systems, acquired 79 shares of the company's common stock.
  • The shares were received in lieu of cash fees, as per the company's Non-Employee Director Compensation Policy.
  • The price per share was $210.46.
  • Following the transaction, Melenikiotou directly owns 2,213 shares of Inspire Medical Systems.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares is generally a good sign, but the amount is small and part of a compensation plan.

Positives

  • The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

Director share acquisitions are common and are usually viewed as a positive sign of confidence in the company's future.

Related Party Transactions

  • The acquisition of shares in lieu of cash fees is a related party transaction, as it involves a director and the company.

Stakeholder Impact

  • The transaction has a minimal impact on stakeholders, as it is a small number of shares acquired by a director as part of their compensation.

Key Dates

DateDescription
10/14/2024Date of transaction: Georgia Melenikiotou acquired 79 shares of Inspire Medical Systems common stock.
10/16/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.